Wu 2014.

Methods	Design: parallel two‐arm randomised controlled trial Setting: China Interventions: acupoint therapy plus half‐dose colchicine versus usual dose colchicine Sample size: sample size calculation not provided Analysis: ITT
Participants	Number of participants Randomised: 64 (32 to the acupoint therapy group and 32 to the colchicine usual dose group) Analysed: 64 (32 to the acupoint therapy group and 32 to the colchicine usual dose group) Inclusion criteria Senile acute gouty arthritis Exclusion criteria Not reported Baseline characteristics Not reported
Interventions	Intervention ‐ acupoint therapy plus half‐dose colchicine Participants were given acupoint application at Quchi, Sanyinjiao, Yinlingquan, Taichong, Zusanli, Ashi and other points besides the half‐colchicine dosage of the control group. Control ‐ usual dose colchicine Participants were treated with colchicine tablets orally according to the normal dose and method. Co‐interventions None reported
Outcomes	Study outcomes Clinical efficacy of acupoint therapy Serum uric acid levels Time to achieve pain relief Adverse events
Notes	Trial registration: not reported Withdrawals: none Adverse events Acupoint therapy nausea and vomiting = 7; diarrhoea = 14; abdominal pain=10; itching = 3 Control nausea and vomiting = 11; diarrhoea = 23; abdominal pain=14; itching = 0

ITT: intention‐to‐treat